Cargando…

A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor

A 50‐year‐old Japanese woman with advanced breast cancer presented with productive cough and dyspnea while she was receiving a sixth cycle of chemotherapy including atezolizumab. Chest computed tomography revealed bronchiolitis and transbronchial lung cryobiopsy revealed eosinophilic bronchiolitis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamura, Akiko, Hashimoto, Masao, Hosoi, Atsuko, Hojo, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317597/ https://www.ncbi.nlm.nih.gov/pubmed/37201911 http://dx.doi.org/10.1111/1759-7714.14931

Ejemplares similares

Immune checkpoint inhibitors‐induced eosinophilic pneumonia: A case report
por: Hara, Kanako, et al.
Publicado: (2021)

Anti‐interleukin 5 antibody is effective for not only severe asthma and eosinophilic pneumonia but also eosinophilic bronchiolitis
por: Tomyo, Fuminori, et al.
Publicado: (2018)

Bronchiolitis obliterans syndrome associated with an immune checkpoint inhibitor in a patient with non-small cell lung cancer
por: Takeda, Kenichiro, et al.
Publicado: (2023)

Eosinophilic bronchiolitis successfully treated with benralizumab
por: Sugino, Keishi, et al.
Publicado: (2021)

Case Report: Eosinophilic Bronchiolitis With Eosinophil ETosis in Mucus Plugs Successfully Treated With Benralizumab
por: Sasaki, Hisashi, et al.
Publicado: (2022)

Development of eosinophilic pneumonia from eosinophilic bronchiolitis without asthma: A case report
por: Mikami, Erika, et al.
Publicado: (2023)

Cardiovascular events after the initiation of immune checkpoint inhibitors
por: Suzuki, Yuta, et al.
Publicado: (2023)

Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection
por: Takano, Tomotsugu, et al.
Publicado: (2021)

Dual checkpoint inhibitor-associated eosinophilic enteritis
por: Yang, J., et al.
Publicado: (2019)

Eosinophilic Fasciitis following Checkpoint Inhibitor Therapy with Pembrolizumab
por: Zampeli, Evangelia, et al.
Publicado: (2021)

Eosinophil Inflammation and Hyperresponsiveness in the Airways as Phenotypes of COPD, and Usefulness of Inhaled Glucocorticosteroids
por: Kume, Hiroaki, et al.
Publicado: (2019)

Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors
por: Simon, Sonja C. S., et al.
Publicado: (2020)

Fatal Immune Checkpoint Inhibitor-related Pancreatitis
por: Ueno, Masayuki, et al.
Publicado: (2021)

Eosinophilic Asthma Secondary to Adjuvant Anti-PD-1 Immune Checkpoint Inhibitor Treatment in a Melanoma Patient
por: Kissoonsingh, P., et al.
Publicado: (2022)

A case of pulmonary adenocarcinoma showing rapid progression of peritoneal dissemination after immune checkpoint inhibitor therapy
por: Shinozaki, Taro, et al.
Publicado: (2018)

Intrahepatic Bile Duct Injury as a Hepatic Immune-Related Adverse Event after Immune-Checkpoint Inhibitor Treatment
por: Murayama, Aiko, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-Associated Scleroderma-Like Syndrome: A Report of a Pembrolizumab-Induced “Eosinophilic Fasciitis-Like” Case and a Review of the Literature
por: Salamaliki, Christina, et al.
Publicado: (2020)

Eosinophil Cationic Protein and Chemokines in Nasopharyngeal Secretions of Infants with Respiratory Syncytial Virus (RSV) Bronchiolitis and Non-RSV Bronchiolitis
por: Kim, Hyun Hee, et al.
Publicado: (2007)

Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO)
por: Manzoni, Paolo
Publicado: (2018)

Bronchiolitis in children: The Saudi initiative of bronchiolitis diagnosis, management, and prevention (SIBRO)
por: Alharbi, Adel S., et al.
Publicado: (2018)

COVID-19 and immune checkpoint inhibitors: initial considerations
por: Sullivan, Ryan J, et al.
Publicado: (2020)

Pathological Complete Response after Immune-Checkpoint Inhibitor Followed by Salvage Surgery for Clinical Stage IV Pulmonary Adenocarcinoma with Continuous Low Neutrophil-to-Lymphocyte Ratio: A Case Report
por: Higuchi, Mitsunori, et al.
Publicado: (2021)

Eosinophilic Granulomatosis with Polyangiitis Initially Diagnosed as Eosinophilic Gastroenteritis
por: Itawaki, Ayako, et al.
Publicado: (2019)

A case of severe acute hemorrhagic duodenitis after administration of immune checkpoint inhibitor
por: Saito, Keita, et al.
Publicado: (2021)

Second primary tumor after immune checkpoint inhibitor therapy: A case report
por: Miao, Kang, et al.
Publicado: (2022)

Refractory Immune Checkpoint Inhibitor-Induced Colitis Improved by Tacrolimus: A Case Report
por: Kunogi, Yasuhito, et al.
Publicado: (2021)

Multiorgan eosinophilic infiltration after initiation of clozapine therapy: a case report
por: Marchel, Dorota, et al.
Publicado: (2017)

Immune checkpoint inhibitors in liver transplant: a case series
por: Rudolph, Mark, et al.
Publicado: (2023)

P14 A rare adverse event of eosinophilic fasciitis secondary to immune checkpoint inhibitor therapy
por: Byravan, Swetha, et al.
Publicado: (2023)

Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature
por: Soto, Felipe, et al.
Publicado: (2023)

Improvement of constrictive bronchiolitis (bronchiolitis obliterans) after rituximab therapy in 2 patients with primary sjögren syndrome
por: Lipatov, Kirill, et al.
Publicado: (2021)

Immunosuppressive therapy ameliorates refractory vasospastic angina, severe pulmonary hypertension, and bronchiolitis in a patient with eosinophilic granulomatosis with polyangiitis: a case report
por: Konno, Ryo, et al.
Publicado: (2018)

Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
por: Fujita, Kohei, et al.
Publicado: (2020)

Severe cryptogenic bronchiolitis: Case report
por: Ramírez, Luis Eduardo, et al.
Publicado: (2023)

Late-Onset Immunotherapy-Induced Myocarditis 2 Years After Checkpoint Inhibitor Initiation
por: Nguyen, Andrew T., et al.
Publicado: (2022)

Anti-Ma2-Associated Limbic Encephalitis after Termination of Immune Checkpoint Inhibitor Therapy for Malignant Pleural Mesothelioma
por: Hashimoto, Rei, et al.
Publicado: (2021)

Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
por: Kuo, Jean R., et al.
Publicado: (2018)

Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
por: Tanabe, Junya, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Induced Hemorrhagic Gastritis
por: Mathialagan, Karthik, et al.
Publicado: (2023)

Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
por: Mayor Ibarguren, Ander, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5k9q29p0csu7og4irvop3n8rtd